about
Toll-like receptor (TLR)-1/2 triggering of multiple myeloma cells modulates their adhesion to bone marrow stromal cells and enhances bortezomib-induced apoptosisTargeting prolyl endopeptidase with valproic acid as a potential modulator of neutrophilic inflammationImmunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammationInterleukin-7 and Toll-like receptor 7 induce synergistic B cell and T cell activationAssociation of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosisCigarette smoke differentially modulates dendritic cell maturation and function in time.Toll-like receptors in human multiple myeloma: new insight into inflammation-related pathogenesis.The matrikine PGP as a potential biomarker in COPD.Human neonatal thymectomy induces altered B-cell responses and auto-reactivity.AllergoOncology - the impact of allergy in oncology: EAACI position paper.Basophil-derived amphiregulin is essential for UVB irradiation-induced immune suppression.Mast cells in neuroinflammation and brain disorders.Mast Cell Degranulation Is Accompanied by the Release of a Selective Subset of Extracellular Vesicles That Contain Mast Cell-Specific Proteases.Comprehensive Proteomic Analysis of Human Milk-derived Extracellular Vesicles Unveils a Novel Functional Proteome Distinct from Other Milk Components.Immunoglobulin Free Light Chains in the Pathogenesis of Lung Disorders.Serum tryptase concentration and progression to end-stage renal disease.Recovery of extracellular vesicles from human breast milk is influenced by sample collection and vesicle isolation procedures.Polyclonal immunoglobulin free light chain and chronic inflammation.Measurement of airway function using invasive and non-invasive methods in mild and severe models for allergic airway inflammation in mice.Immunoglobulinfree light chains reduce in an antigen-specific manner the rate of rise of action potentials of mouse non-nociceptive dorsal root ganglion neurons.AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer.'Corrigendum to "Mast cells in neuroinflammation and brain disorders"[Neurosci. Biobehav. Rev. 79 (2017) 119-133]'.Mast Cells as Drivers of Disease and Therapeutic Targets.Non-IgE mediated mast cell activation.Effects of the polyunsaturated fatty acids, EPA and DHA, on hematological malignancies: a systematic review.Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases.Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast CellsComparing biologicals and small molecule drug therapies for chronic respiratory diseasesPredictable Irreversible Switching Between Acute and Chronic InflammationHuman mast cells promote colon cancer growth via bidirectional crosstalk: studies in 2D and 3D coculture modelsA Transcriptomic Insight into the Impact of Colon Cancer Cells on Mast CellsAllergoOncology: Microbiota in allergy and cancer-A European Academy for Allergy and Clinical Immunology position paper.Serum immunoglobulin free light chain levels are higher in girls than boys during eosinophilic oesophagitisButyrate inhibits human mast cell activation via epigenetic regulation of FcεRI-mediated signalingEPA and DHA have selective toxicity for PBMCs from multiple myeloma patients in a partly caspase-dependent mannerMolecular Insights into the Mechanism of Necroptosis: The Necrosome As a Potential Therapeutic TargetPrefaceProline-Glycine-Proline Peptides Are Critical in the Development of Smoke-induced EmphysemaRole of Mast Cells in Shaping the Tumor MicroenvironmentPreface
P50
Q28538422-69C8520B-537B-403F-8F46-6A636F830AC4Q33623637-E15B1499-7DA3-45F6-B238-F14C4370CF7CQ33917584-3D5660CE-CFF5-4738-A35A-D89DFA4C3701Q35150725-9CA2ABF1-D06C-4266-92C1-D1E2838C3869Q35372594-7B238686-BE9D-4864-BBAE-E7715697942CQ36203621-F7711869-23B4-46CE-9CD0-69C91366362CQ38204480-5CF821DF-2D14-4B12-A63C-644C83F287C2Q38511985-7D742ABA-BEA5-4CEB-B6AC-35770818137CQ38686764-1C7970CD-B65A-4565-910E-11924FCA4E45Q38776716-6DDDD0AD-FD27-4B7C-A96D-1A086B25BDE0Q39247966-56072773-C2D2-4DDB-8560-38AFA0D3C26EQ39302923-E5463ACC-96BB-40D3-A85E-D5363A180EDCQ39399289-2E57823E-07A0-4B3D-AC36-1C3ADFDD809CQ39416049-46241394-E70D-4D8E-B87A-80F8A0B8336DQ40060560-ADAA8421-76E9-460E-B619-FFFD0207BD6FQ40747225-7F5168C7-DE25-4001-80C8-AC2FAF225384Q41607523-EB6C901C-6A8A-4177-B4AB-BF2E15C0F773Q42337324-3538BBDE-E119-461B-8E83-54C5306D7247Q42784339-51013E4B-7698-45E0-B233-7E9DFF7ADC35Q44791879-EFBA36F1-CBAE-4532-A9AF-6F1F715AF036Q46132734-26F6E69C-D7C9-48FF-8567-39B73677FE39Q47986623-9A245B28-126C-402A-9406-99AFE3391852Q49357745-D2693834-09B3-40B4-AE3F-035A65758C74Q50069011-5841181C-CCCC-40D0-9F85-8D561055F0C9Q52726199-AADB5B69-264F-46F8-9E71-146BDE1063CFQ55079819-DD1EC25B-D760-40AE-874E-3B18EE617224Q57191727-C06A651A-906E-443E-879F-137D65867A47Q57789437-9AEDF485-ED84-45E4-96F1-1BA63EAB5822Q58034049-8269F837-E0FB-437B-970E-0E1432A132AAQ58129602-B00D8550-A8F1-4DDA-9155-E70D873A2233Q64076623-EF84D765-4314-4667-AB0D-79A4F745EAC1Q64949336-F65C7525-EC2D-43FE-A3EC-6F8A64BF8A27Q87606621-C85C5057-45B9-4DF0-ABA4-54972190F9FDQ89950234-DA910345-367C-454B-B67D-CCEBE936E419Q90314323-E44B8C38-A907-46E4-94F0-D5A5C92DCCE4Q91445011-20696736-A64D-407F-A06C-1359E5A3258FQ92878702-41989377-8BCD-47C6-8823-12411E462D87Q92929704-DE6E9FF9-2427-455B-B42D-AB75F375652EQ93133243-8F41C47A-70EB-43E2-807C-5AEA0BE74B93Q95569694-3B9A9CAB-5941-4B7D-B03E-B60F8F3A361B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Frank A Redegeld
@en
Frank A Redegeld
@nl
type
label
Frank A Redegeld
@en
Frank A Redegeld
@nl
prefLabel
Frank A Redegeld
@en
Frank A Redegeld
@nl
P31
P496
0000-0001-8830-7960